首页 | 本学科首页   官方微博 | 高级检索  
     


Hyperinsulinemic Hypoglycemia
Affiliation:1. Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China;2. Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China;3. Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China;1. The Congenital Hyperinsulinism Center and the Department of Surgery at the Children’s Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;2. The Congenital Hyperinsulinism Center and the Department of Pediatrics at the Children’s Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;3. The Congenital Hyperinsulinism Center and the Department of Pathology at the Children’s Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;4. The Congenital Hyperinsulinism Center and the Department of Radiology at the Children’s Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Abstract:
Keywords:Hyperinsulinism  Hypoglycemia  Diazoxide  Octreotide  Mammalian target of rapamycin (mTOR) inhibitor  Pancreatectomy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号